Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1998-05-01
2000-01-11
Kumar, Shailendra
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514617, 514821, 514825, 514826, 514863, 514886, 514908, 514927, A61K 31165
Patent
active
06013674&
ABSTRACT:
This invention provides novel indenone derivatives, their pharmaceutical formulations and their use for the inhibition of leukocyte adherence to cells.
REFERENCES:
patent: 3453287 (1969-07-01), Campaigne et al.
patent: 3622623 (1971-11-01), Shen et al.
patent: 3763229 (1973-10-01), Noguchi et al.
patent: 3822310 (1974-07-01), Shen et al.
patent: 3932498 (1976-01-01), Shen et al.
patent: 3956363 (1976-05-01), Shen et al.
patent: 3976634 (1976-08-01), Nadelson et al.
patent: 3985729 (1976-10-01), Houlihan et al.
patent: 4760086 (1988-07-01), Tischler et al.
patent: 5208253 (1993-05-01), Boschelli et al.
patent: 5521213 (1996-05-01), Prasit et al.
Moussa, et al., "Polycyclic aromatic compounds, synthesis and biological screening of some new naphthalene, 1-indenone and benzo[c]fluorenone compounds", Journal of Polish Chemistry, vol. 55, No. 11, 1981, pp. 2445-2456.
Barvian et al., "1-Oxo-3-aryl-1H-Indene-2-carboxylic acid derivatives as selective inhibitors of fibroplast growth factor receptor-1 tyrosin kinase", Biorganic and Medicinal Chemistry Letters, vol. 7, No. 22, 1997, pp. 2903-2908.
Boschelli, et al., "3-Alkoxybenzo[b]thiophene-2-carboxamides as Inhibitors of Neutrophil-Endothelial Cell Adhesion", Journal of Medicinal Chemistry, vol. 37, No. 6, Mar. 18, 1994, pp. 717-718.
Smith, et al., "Recognition of an Endothelial Determinant for CD18-dependent Human Neutrophil Adherence and Transendothelial Migration", J. Clin. Invest., vol. 82, Nov. 1988, pp. 1746-1756.
Wright, et al., "Selective regulation of human neutrophil functions by the cell activation inhibitor CI-959", Journal of Leukocyte Biology, vol. 55, Apr. 1994, pp. 443-451.
Campaigne, et al., "Cyclization of Ylidenemalononitriles. X. Synthesis of Benzazapropellane Derivatives from .alpha.-Cyano-.beta.-chloroalkylcinnamonitriles (1a)", Journal of Heterocyclic Chemistry, vol. 14, No. 8, Dec. 1977, pp. 1337-1345.
Bestmann, et al., "Syntheses von cyclischen Verbindungen aus Triphenyl[(phenylimino)ethenyliden]phosphoran and Oxocarbonsauren--Eine neue Anellierungsmethodik", Chem Ber., 118, pp. 2640-2658 (1985).
Jackson William Thomas
Kinnick Michael Dean
Morin, Jr. John Michael
Vasileff Robert Theodore
Barrett Brian P.
Eli Lilly and Company
Kumar Shailendra
McNeil Scott Alexander
Strode Janelle D.
LandOfFree
Cell adhesion inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell adhesion inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell adhesion inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1462717